RAP 0.00% 20.5¢ raptor resources limited

What to expect if Pfizer's takeover fails, page-100

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
  1. 488 Posts.
    lightbulb Created with Sketch. 134
    Looking at life after the No Vote needs to look at all the parts that form Rap

    The primary product is DX - it diagnoses Respiratory Diseases, is used for Telehealth, is needed for Triage and Monitoring of Respiatory conditions - this is what Rap is about using AI for health and hospitals, - it has huge potential.

    Then we have Covid Detection that has the attention of Pfizer and also has high potential.

    And let’s not forget Sleepcheck - it now has FDA approval and can accurately detect sleep apnoea

    It is my thinking that we should sell either Sleepcheck or our Covid detection

    Other people here would have a better idea of what we could get but companies like Resmed would sell a lot more machines with a cheap means of identifying sleep apnoea - I would think $20mil plus

    This would give us the money to properly develop DX without the problem of take overs and capital raising.

    Rap is to good to give away, - it does give a voice, vision,and analysis of sensory data utilising AI
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.